-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Astrana Health, Lowers Price Target to $37

Benzinga·11/25/2025 19:48:19
Listen to the news
Jefferies analyst Jack Slevin maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $44 to $37.